Alenson Carman has filed 13 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 140000 shares of Prime Medicine, Inc. ($PRME) on February 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 180,510,658 | 9999.99% | 0.08% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 16083 | $0.00 | 16,083.0000 | 131,160,842 | 9999.99% | 0.01% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | D | Stock Option (right to buy) | 90498 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.07% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 90498 | $0.00 | 90,498.0000 | 131,160,842 | 9999.99% | 0.07% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | D | Stock Option (right to buy) | 6254 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.00% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 6254 | $0.00 | 6,254.0000 | 131,160,842 | 9999.99% | 0.00% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | D | Stock Option (right to buy) | 16083 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.01% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 90498 | $0.00 | 90,498.0000 | 131,160,842 | 9999.99% | 0.07% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | D | Stock Option (right to buy) | 90498 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.07% |
| Feb. 27, 2025 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 90500 | $0.00 | 90,500.0000 | 131,160,842 | 9999.99% | 0.07% |
| Feb. 21, 2024 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 90498 | $0.00 | 90,498.0000 | 0 | 9999.99% | 0.00% |
| April 18, 2023 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 6254 | $0.00 | 6,254.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | Prime Medicine, Inc. | $PRME | Alenson Carman | See Remarks | A | Stock Option (right to buy) | 90498 | $0.00 | 90,498.0000 | 0 | 9999.99% | 0.00% |